4 Department of Neurosurgery, Royal Prince Alfred Hospital, Camperdown, Sidney, Australia Correspondence to: Dr Nicholas Higgins Department of Radiology, Box 219, Addenbrooke’s Hospital, Hills Road, ...

Dr Ryuji Sakakibara, Department of Neurology Chiba University 1–8–1 Inohana, Chuo-ku, Chiba 260–8670 Japan. Telephone 0081 43 226 2129; fax 0081 43 226 2160; emailsakaki{at}med.m.chiba-u.ac.jp ...

Correspondence to Professor Massimo Filippi, Neuroimaging Research Unit, Division of Neuroscience; Neurology Unit; Neurorehabilitation Unit; and Neurophysiology Service, IRCCS San Raffaele Scientific ...

1 Rush Institute for Healthy Aging, Centers for Disease Control and Prevention, Atlanta, GA, USA 2 Department of Internal Medicine, Centers for Disease Control and Prevention, Atlanta, GA, USA 3 ...

OBJECTIVES To clarify the nosological relation among Miller Fisher syndrome (MFS), Guillain-Barré syndrome (GBS) with ophthalmoplegia, Bickerstaff's brain stem encephalitis (BBE), and acute ...

7 Department of Neurology, Queen Elizabeth Hospital, Edgbaston, Birmingham, UK 8 Department of Neurology, King's College Hospital and King's College School of Medicine, London, UK Correspondence to Dr ...

The palmomental reflex, an involuntary contraction of the mentalis muscle of the chin caused by stimulation of the thenar eminence, can be tested easily and rapidly. Its presence may alert the ...

Objective: Parkinson’s disease (PD) is a progressive neurological disorder characterised by a large number of motor and non-motor features that can impact on function to a variable degree. This review ...

Parkinson’s disease (PD) is an incurable and progressive neurological disorder leading to deleterious motor and non-motor consequences. Presently, no pharmacological agents can prevent PD evolution or ...

Correspondence to Dr Michael A van Es, Department of Neurology, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht 3584 CX, The Netherlands; M.A.vanEs{at}umcutrecht.nl Objectives ...

From 1979-85, 2435 patients with a transient ischaemic attack or minor ischaemic stroke were randomly allocated to receive long term "blind" treatment with aspirin 600 mg twice daily (n = 815), ...